BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18604872)

  • 1. Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator.
    Nguyen Huu NS; Ryder WD; Zeps N; Flasza M; Chiu M; Hanby AM; Poulsom R; Clarke RB; Baron M
    J Pathol; 2008 Sep; 216(1):93-102. PubMed ID: 18604872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amplified WWP1 gene is a potential molecular target in breast cancer.
    Chen C; Zhou Z; Ross JS; Zhou W; Dong JT
    Int J Cancer; 2007 Jul; 121(1):80-87. PubMed ID: 17330240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
    Chen C; Zhou Z; Sheehan CE; Slodkowska E; Sheehan CB; Boguniewicz A; Ross JS
    Int J Cancer; 2009 Jun; 124(12):2829-36. PubMed ID: 19267401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN and NEDD4 in Human Breast Carcinoma.
    Chen Y; van de Vijver MJ; Hibshoosh H; Parsons R; Saal LH
    Pathol Oncol Res; 2016 Jan; 22(1):41-7. PubMed ID: 26276352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evaluation of WBP2NL-Related Genes Expression in Breast Cancer.
    Nourashrafeddin S; Aarabi M; Modarressi MH; Rahmati M; Nouri M
    Pathol Oncol Res; 2015 Apr; 21(2):293-300. PubMed ID: 25417742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer.
    Zhou Z; Liu R; Chen C
    Int J Cancer; 2012 Apr; 130(7):1504-10. PubMed ID: 21480222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.
    Li Y; Zhou Z; Alimandi M; Chen C
    Oncogene; 2009 Aug; 28(33):2948-58. PubMed ID: 19561640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11.
    Chen C; Zhou Z; Liu R; Li Y; Azmi PB; Seth AK
    Oncogene; 2008 Nov; 27(54):6845-55. PubMed ID: 18724389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.
    Subik K; Shu L; Wu C; Liang Q; Hicks D; Boyce B; Schiffhauer L; Chen D; Chen C; Tang P; Xing L
    Bone; 2012 Apr; 50(4):813-23. PubMed ID: 22266093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
    Chen C; Sun X; Guo P; Dong XY; Sethi P; Cheng X; Zhou J; Ling J; Simons JW; Lingrel JB; Dong JT
    J Biol Chem; 2005 Dec; 280(50):41553-61. PubMed ID: 16223724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway.
    Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L
    Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the nuclear localization of the human Nedd4-related WWP1 protein by Notch.
    Flasza M; Nguyen Huu NS; Mazaleyrat S; Clémence S; Villemant C; Clarke R; Baron M
    Mol Membr Biol; 2006; 23(3):269-76. PubMed ID: 16785210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
    Li Y; Zhou Z; Chen C
    Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
    Luhtala S; Staff S; Kallioniemi A; Tanner M; Isola J
    BMC Cancer; 2018 Oct; 18(1):1045. PubMed ID: 30367623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
    Yeung B; Ho KC; Yang X
    PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WWP1 gene is a potential molecular target of human oral cancer.
    Lin JH; Hsieh SC; Chen JN; Tsai MH; Chang CC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):221-31. PubMed ID: 23849376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal expression of WWP1 in chronic lymphocytic leukemia and its clinical significance].
    Yang CQ; Cao L; Huang R; Liu HL; Wu YJ; Qiao C; Xu W; Li JY; Fan L
    Zhonghua Xue Ye Xue Za Zhi; 2020 Sep; 41(9):737-742. PubMed ID: 33113605
    [No Abstract]   [Full Text] [Related]  

  • 19. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
    Cheng Q; Cao X; Yuan F; Li G; Tong T
    Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.
    Chen C; Sun X; Guo P; Dong XY; Sethi P; Zhou W; Zhou Z; Petros J; Frierson HF; Vessella RL; Atfi A; Dong JT
    Oncogene; 2007 Apr; 26(16):2386-94. PubMed ID: 17016436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.